Perceptive Advisors as of March 31, 2012
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 72 positions in its portfolio as reported in the March 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 9.4 | $40M | 510k | 77.52 | |
Ariad Pharmaceuticals | 8.5 | $36M | 2.2M | 15.98 | |
Neurocrine Biosciences (NBIX) | 6.9 | $29M | 3.6M | 7.97 | |
Questcor Pharmaceuticals | 6.8 | $29M | 760k | 37.62 | |
Vivus | 6.6 | $28M | 1.2M | 22.36 | |
Mylan | 4.7 | $20M | 840k | 23.45 | |
Arena Pharmaceuticals | 4.7 | $20M | 6.4M | 3.08 | |
Aegerion Pharmaceuticals | 4.5 | $19M | 1.4M | 13.83 | |
Capital Senior Living Corporation | 3.5 | $15M | 1.6M | 9.24 | |
Express Scripts | 3.2 | $14M | 250k | 54.18 | |
Medivation | 3.0 | $12M | 166k | 74.72 | |
Illumina (ILMN) | 2.5 | $11M | 200k | 52.61 | |
Repros Therapeutics | 2.3 | $9.8M | 2.3M | 4.23 | |
Keryx Biopharmaceuticals | 2.3 | $9.5M | 1.9M | 4.98 | |
Human Genome Sciences | 2.1 | $8.8M | 1.1M | 8.24 | |
Neptune Technologies Bioreso | 2.1 | $8.6M | 2.7M | 3.15 | |
AVI BioPharma ComStk Usd0.0001 | 2.0 | $8.6M | 5.6M | 1.54 | |
Biogen Idec (BIIB) | 1.8 | $7.3M | 58k | 126.01 | |
Seattle Genetics | 1.5 | $6.1M | 300k | 20.38 | |
Synta Pharmaceuticals | 1.2 | $5.2M | 1.2M | 4.39 | |
Amylin Pharmaceuticals | 1.2 | $5.0M | 200k | 24.96 | |
Universal Health Services (UHS) | 1.2 | $4.9M | 118k | 41.91 | |
GlaxoSmithKline | 1.2 | $4.9M | 110k | 44.91 | |
Protalix BioTherapeutics | 1.1 | $4.8M | 750k | 6.37 | |
Infinity Pharmaceuticals (INFIQ) | 1.1 | $4.7M | 396k | 11.96 | |
EXACT Sciences Corporation (EXAS) | 1.1 | $4.6M | 415k | 11.13 | |
Onyx Pharmaceuticals | 1.1 | $4.5M | 120k | 37.68 | |
Endo Pharmaceuticals | 1.0 | $4.3M | 110k | 38.73 | |
Sunrise Senior Living | 1.0 | $4.2M | 668k | 6.32 | |
WellPoint | 0.9 | $3.7M | 50k | 73.80 | |
HeartWare International | 0.8 | $3.4M | 53k | 65.70 | |
Alnylam Pharmaceuticals (ALNY) | 0.8 | $3.4M | 310k | 11.07 | |
Coronado Biosciences Inc. Common | 0.7 | $2.8M | 331k | 8.46 | |
Sagent Pharmaceuticals | 0.6 | $2.5M | 140k | 17.87 | |
Ardea Biosciences | 0.6 | $2.4M | 111k | 21.76 | |
Cutera (CUTR) | 0.6 | $2.4M | 281k | 8.55 | |
Athersys | 0.5 | $2.3M | 1.5M | 1.55 | |
Array BioPharma | 0.5 | $2.1M | 620k | 3.40 | |
XOMA CORP Common equity shares | 0.5 | $2.0M | 730k | 2.77 | |
Progenics Pharmaceuticals | 0.3 | $1.4M | 144k | 9.90 | |
Syneron Medical Ltd ord | 0.3 | $1.3M | 121k | 10.72 | |
Neostem (NBS) | 0.3 | $1.3M | 3.3M | 0.38 | |
Dendreon Corporation | 0.3 | $1.1M | 100k | 10.66 | |
Accuray | 0.2 | $1.1M | 150k | 7.06 | |
Dynavax Technologies Corporation | 0.2 | $1.0M | 199k | 5.03 | |
Trinity Biotech | 0.2 | $933k | 88k | 10.67 | |
Ligand Pharmaceuticals In (LGND) | 0.2 | $916k | 57k | 15.96 | |
Celldex Therapeutics | 0.2 | $713k | 140k | 5.09 | |
Clovis Oncology | 0.1 | $582k | 23k | 25.46 | |
Pharmacyclics | 0.1 | $555k | 20k | 27.75 | |
Immunomedics | 0.1 | $526k | 145k | 3.63 | |
Idenix Pharmaceuticals | 0.1 | $490k | 50k | 9.80 | |
Achillion Pharmaceuticals | 0.1 | $479k | 50k | 9.58 | |
Endologix | 0.1 | $440k | 30k | 14.67 | |
Raptor Pharmaceutical | 0.1 | $423k | 63k | 6.77 | |
Response Genetics (RGDXQ) | 0.1 | $396k | 198k | 2.00 | |
Orexigen Therapeutics | 0.1 | $309k | 75k | 4.10 | |
BioMimetic Therapeutics | 0.1 | $247k | 100k | 2.47 | |
Oncothyreon | 0.1 | $206k | 47k | 4.36 | |
Synergy Pharmaceuticals | 0.1 | $203k | 50k | 4.06 | |
Chemocentryx | 0.1 | $220k | 21k | 10.68 | |
LeMaitre Vascular (LMAT) | 0.0 | $176k | 30k | 5.91 | |
Tenet Healthcare Corporation | 0.0 | $106k | 20k | 5.30 | |
Angeion Corporation | 0.0 | $109k | 19k | 5.76 | |
Senesco Technologies | 0.0 | $112k | 446k | 0.25 | |
Apricus Bioscience | 0.0 | $113k | 40k | 2.82 | |
Conceptus | 0.0 | $36k | 2.5k | 14.40 | |
ArQule | 0.0 | $44k | 6.3k | 6.98 | |
Community Health Systems (CYH) | 0.0 | $56k | 2.5k | 22.40 | |
3SBio (SSRX) | 0.0 | $37k | 2.5k | 14.80 | |
Uroplasty | 0.0 | $45k | 15k | 3.00 | |
Combimatrix Corporation *w exp 05/01/201 | 0.0 | $7.0k | 50k | 0.14 |